{"transactions":[{"id":1174244,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":80893,"kind":"organization","name":"Pembroke & Partners LLC","position":1,"cik":"0002056785","reported_name":"Pembroke & Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-04-10T13:54:22.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":1679182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Pembroke purchased an aggregate of 984 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the \"Preferred Stock\") with a stated value of $1,000 per share of Preferred Stock, and 3,358,364 Warrants for gross proceeds of $984,000. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 492 shares of Preferred Stock and 1,679,182 Warrants."}],"balance_after":3358364,"derivative":{"exercise_price":0.6446,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock","underlying_shares":1679182},"source":{"system":"sec-edgar","filing":"0001477932-25-002580","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056785/000147793225002580/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1174243,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":80893,"kind":"organization","name":"Pembroke & Partners LLC","position":1,"cik":"0002056785","reported_name":"Pembroke & Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-04-10T13:54:22.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":492,"price":1000,"value":492000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Pembroke purchased an aggregate of 984 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the \"Preferred Stock\") with a stated value of $1,000 per share of Preferred Stock, and 3,358,364 Warrants for gross proceeds of $984,000. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 492 shares of Preferred Stock and 1,679,182 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each holder of Preferred Stock is entitled to vote on an as-converted to Common Stock basis with a per share voting price of $0.6393, granting Pembroke voting power based on the Preferred Stock of up to 23% of the outstanding Common Stock. Pembroke's beneficial ownership is subject to a 9.99% limit on the shares of Common Stock issuable upon conversion of the Preferred Stock and a 4.99% limit on the shares of Common Stock issuable upon exercise of the Warrants."}],"balance_after":984,"derivative":{"exercise_price":0.586,"exercise_date":"2025-04-04","underlying":"Common Stock","underlying_shares":839591},"source":{"system":"sec-edgar","filing":"0001477932-25-002580","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056785/000147793225002580/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}}]}